| Literature DB >> 26198736 |
Traute Janßen1,2, Matthias Voss3, Michael Kühl4,5, Torsten Semmler6, Hans-Christian Philipp7, Christa Ewers8.
Abstract
Erysipelothrix rhusiopathiae infections re-emerged as a matter of great concern particularly in the poultry industry. In contrast to porcine isolates, molecular epidemiological traits of avian E. rhusiopathiae isolates are less well known. Thus, we aimed to (i) develop a multilocus sequence typing (MLST) scheme for E. rhusiopathiae, (ii) study the congruence of strain grouping based on pulsed-field gel electrophoresis (PFGE) and MLST, (iii) determine the diversity of the dominant immunogenic protein SpaA, and (iv) examine the distribution of genes putatively linked with virulence among field isolates from poultry (120), swine (24) and other hosts (21), including humans (3). Using seven housekeeping genes for MLST analysis we determined 72 sequence types (STs) among 165 isolates. This indicated an overall high diversity, though 34.5% of all isolates belonged to a single predominant ST-complex, STC9, which grouped strains from birds and mammals, including humans, together. PFGE revealed 58 different clusters and congruence with the sequence-based MLST-method was not common. Based on polymorphisms in the N-terminal hyper-variable region of SpaA the isolates were classified into five groups, which followed the phylogenetic background of the strains. More than 90% of the isolates harboured all 16 putative virulence genes tested and only intI, encoding an internalin-like protein, showed infrequent distribution. MLST data determined E. rhusiopathiae as weakly clonal species with limited host specificity. A common evolutionary origin of isolates as well as shared SpaA variants and virulence genotypes obtained from avian and mammalian hosts indicates common reservoirs, pathogenic pathways and immunogenic properties of the pathogen.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26198736 PMCID: PMC4509749 DOI: 10.1186/s13567-015-0216-x
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Primer sets used to amplify and sequence E. rhusiopathiae housekeeping genes and genetic diversity of gene loci used for MLST analysis
| Gene | Primer sequence [5′-3′] | Location within genea | Amplicon size PCR (bp) | Allele size MLST (bp) | Mean GC content | No. of alleles | No. of variable sites (%) |
| Simpsons index of diversity ( |
|---|---|---|---|---|---|---|---|---|---|
|
| fw: AGTTATGATGTGGGGACG | 75-745 | 671 | 540 | 38.3% | 9 | 11 (2.0) | 0.3610 | 0.608 |
| rv: TAGCTGTAACGACGAGATCG | |||||||||
|
| fw: TTCGGTAGAATAATCTCGCG | 38-913 | 876 | 640 | 39.7% | 9 | 13 (1.6) | 0.0207 | 0.775 |
| rv: TGCTATTAGTTCAGGGTCG | |||||||||
|
| fw: GATGTTTATGAGGAAGCGC | 331-1066 | 736 | 611 | 39.1% | 14 | 11 (1.8) | 0.5690 | 0.764 |
| rv: AACGCATTGATTGTTGCCC | |||||||||
|
| fw: TGCTGCAGTACGTTTAGC | 90-793 | 704 | 544 | 36.6% | 9 | 12 (2.2) | 0.0419 | 0.579 |
| rv: AGACACGTGCATTACCTG | |||||||||
|
| fw: ACAAGTTCACCAGTAAGTG | 190-952 | 763 | 575 | 39.3% | 6 | 4 (0.7) | 0.0654 | 0.657 |
| rv: AGAGTGTACTTACAGGAGT | |||||||||
|
| fw: TATTCCTAATGGAGCGGG | 357-1041 | 685 | 554 | 36.8% | 13 | 10 (1.8) | 0.0766 | 0.740 |
| rv: AATCGCAATCGCACATCC | |||||||||
|
| fw: AACGGATATGAAGCTGTTGCC | 136-783 | 648 | 531 | 40.3% | 11 | 14 (2.6) | 0.3390 | 0.681 |
| rv: AAGAACATCCAGTCCAACAGC |
aAs referred to E. rhusiopathiae ATCC 19414T (Acc.-No. NZ_ACLK02000001 - NZ_ACLK02000004).
Oligonucleotide primers used for multiplex PCRs to detect 16 genes putatively linked with virulence of E. rhusiopathiae
| Gene / locus tag | Gene product / predicted function [reference] | Primer sequence (5′ – 3′) (forward/reverse)a | GenBank Acc. No | Localization within gene | Size (bp) | Gene pre-valence (%) |
|---|---|---|---|---|---|---|
| ERH_1356 | ABC transporter metal-binding protein / adhesion of host cells [ | CATGAAGGGTAACACCTTGG/ GGGCGATAAAGTTGCGGTAGAA | NC_015601.1 | 579 – 787 | 209 | 100 |
|
| Internalin / invasion of epithelial cells [ | ACAGTTTCGGATACTTCCGG/ ACCCTCGTCATATTTACCAGC | AP012027.1 | 386 – 714 | 329 | 85.5 |
|
| Rhusiopathiae surface protein /biofilm formation [ | ATCTTTACCCAATTCGACGT/ ATGAACCCAGTCCAAGATTGG | AB052682.1 | 6882 – 7287 | 406 | 100 |
|
| Rhusiopathiae surface protein /biofilm formation [ | ATCGACTGGTATTCAGTTGG/ ATCACGAGACATACCGCCAA | AB052682.1 | 597 – 1131 | 535 | 100 |
|
| Capsule / resistance to phagocytosis, intracellular survival [ | TATCTTTGTAGCGTAGTTGG/ CAATAAAAGGAAATACCAGTGC | D64177 | 1333 – 1987 | 645 | 100 |
|
| Alginate-O-acetyltransferase / resistance to phagocytosis [ | AGTTATCTTGGACTTGGTCC/ AGATAAGTGCGCATTGATCC | AP012027.1 | 121 – 887 | 767 | 97.6 |
|
| Lipoprotein / adhesion to host cells [ | TAATATTAGATAGCGAGGAAT/ AAGAAAAGGGAGTGTGAATAT | U52850.1 | 226 –1185 | 960 | 100 |
|
| Neuraminidase / spreading factor, nutritive [ | ATGAAGCGCTTACATTTGAAT/ TACATAAGGTTGACCAAAGTC | AB019122 | 295 –1401 | 1.107 | 100 |
|
| S8-subtilisin / peptidase [ | AAGCCTGAGATATCTGCACC/ TTGTACAATTGGATGAGCCG | AP012027.1 | 1360 –1585 | 226 | 100 |
|
| Superoxide dismutase / antioxidans [ | AGAAGACATCCGCACAGCAGT/ GCATGTTCCCAAACATCAAGA | AP012027.1 | 195 – 509 | 315 | 100 |
|
| Integral membrane protein / cell adhesion, transport protein [ | AAATCATGCTTGTAATGGCGG/ ATTCGACGTTAAAACAACCGC | AP012027.1 | 565 –1032 | 378 | 100 |
|
| Heparinase / inactivation of heparin [ | ATGGAAGTACCGATCTCACT/ TCATTGTAGCAACATGGCTTC | AP012027.1 | 997 –1480 | 484 | 100 |
|
| Hemolysin / lytic activity on red blood cells [ | TACGATTGCGACAAAGTGTGCG/ ATGGAAACATAGGGAAGGCTG | AP012027.1 | 16 – 559 | 544 | 100 |
|
| Fibronectin-binding protein / adhesion [ | ATCTCGCCGCTTTTAGAACG/ GCGTCTTCAACTGTTGCTTG | AP012027.1 | 565 –1166 | 602 | 100 |
|
| Hyaluronidase / spreading factor [ | AGGATCACTTACCGCTATGG/ CAGCACTCAGCATGTTCTC | AP012027.1 | 598 –1538 | 941 | 100 |
|
| Membrane-, attachment protein / proliferation, adhesion [ | AATAGCCCCTGATCAAATGG/ CTCTCCTTTACTTAACATCCC | ACLK02000002.1 | 39 –1155 | 1.117 | 99.4 |
Primers were designed in this study except for the primers to amplify the cap locus [46].
aIn case Ogawa et al. [45] is given as a reference, the predicted function of the gene product has been deduced from genome annotation data of strain Fujisawa. Here, in vitro or in vivo studies would be mandatory to verify the linkage of the genes with the pathogenesis of Erysipelas in different hosts.
Sequence types (ST) with corresponding allele numbers demonstrated for 165 E. rhusiopathiae and number of each ST
| ST |
|
|
|
|
|
|
| n |
|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 3 | 1 | 1 | 4 | 4 | 4 | 2 |
| 2 | 1 | 3 | 1 | 3 | 1 | 1 | 1 | 4 |
| 3 | 2 | 4 | 3 | 2 | 2 | 2 | 2 | 6 |
| 4 | 2 | 4 | 2 | 2 | 2 | 5 | 2 | 11 |
| 5 | 2 | 4 | 4 | 2 | 2 | 2 | 3 | 10 |
| 6 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| 7 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 6 |
| 8 | 1 | 1 | 1 | 1 | 1 | 4 | 1 | 3 |
| 9 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 18 |
| 10 | 1 | 1 | 6 | 2 | 2 | 2 | 2 | 4 |
| 11 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 |
| 12 | 1 | 2 | 1 | 1 | 1 | 4 | 1 | 2 |
| 13 | 2 | 4 | 2 | 2 | 4 | 6 | 2 | 2 |
| 14 | 3 | 2 | 1 | 1 | 1 | 3 | 1 | 1 |
| 15 | 2 | 4 | 7 | 2 | 4 | 6 | 2 | 1 |
| 16 | 2 | 5 | 8 | 2 | 4 | 2 | 2 | 1 |
| 17 | 2 | 1 | 6 | 1 | 2 | 5 | 2 | 1 |
| 18 | 2 | 5 | 5 | 2 | 2 | 2 | 3 | 1 |
| 19 | 2 | 4 | 9 | 1 | 1 | 1 | 2 | 5 |
| 20 | 2 | 4 | 4 | 2 | 2 | 2 | 4 | 2 |
| 21 | 1 | 1 | 1 | 1 | 1 | 7 | 1 | 1 |
| 22 | 3 | 2 | 1 | 4 | 1 | 3 | 1 | 1 |
| 23 | 1 | 1 | 1 | 1 | 3 | 4 | 1 | 1 |
| 24 | 4 | 2 | 6 | 2 | 2 | 2 | 2 | 1 |
| 25 | 5 | 3 | 2 | 5 | 4 | 1 | 1 | 1 |
| 26 | 1 | 4 | 1 | 1 | 1 | 5 | 1 | 2 |
| 27 | 2 | 5 | 3 | 2 | 2 | 2 | 3 | 3 |
| 28 | 2 | 5 | 6 | 2 | 2 | 2 | 2 | 1 |
| 29 | 1 | 6 | 1 | 1 | 1 | 4 | 1 | 1 |
| 30 | 1 | 3 | 11 | 1 | 1 | 1 | 1 | 1 |
| 31 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 1 |
| 32 | 5 | 1 | 1 | 1 | 1 | 1 | 1 | 5 |
| 33 | 2 | 1 | 3 | 2 | 1 | 1 | 2 | 1 |
| 34 | 2 | 2 | 6 | 2 | 2 | 5 | 2 | 1 |
| 35 | 1 | 7 | 12 | 6 | 1 | 5 | 7 | 1 |
| 36 | 1 | 2 | 6 | 2 | 2 | 5 | 2 | 2 |
| 37 | 6 | 1 | 1 | 2 | 1 | 4 | 1 | 2 |
| 38 | 2 | 5 | 10 | 2 | 4 | 5 | 3 | 1 |
| 39 | 2 | 5 | 3 | 2 | 2 | 5 | 2 | 2 |
| 40 | 2 | 4 | 1 | 7 | 4 | 2 | 3 | 4 |
| 41 | 2 | 2 | 2 | 2 | 4 | 2 | 2 | 1 |
| 42 | 2 | 5 | 3 | 2 | 2 | 8 | 2 | 1 |
| ST |
|
|
|
|
|
|
| n |
| 43 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 |
| 44 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| 45 | 1 | 3 | 1 | 1 | 1 | 1 | 9 | 1 |
| 46 | 1 | 3 | 13 | 1 | 1 | 1 | 1 | 1 |
| 47 | 2 | 4 | 2 | 8 | 2 | 6 | 3 | 2 |
| 48 | 2 | 2 | 2 | 2 | 5 | 1 | 2 | 7 |
| 49 | 2 | 2 | 14 | 2 | 2 | 2 | 8 | 2 |
| 50 | 2 | 5 | 2 | 2 | 4 | 5 | 2 | 1 |
| 51 | 1 | 2 | 2 | 1 | 4 | 10 | 10 | 1 |
| 52 | 5 | 8 | 1 | 1 | 1 | 1 | 9 | 1 |
| 53 | 6 | 2 | 1 | 1 | 1 | 9 | 1 | 1 |
| 54 | 7 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| 55 | 2 | 2 | 3 | 2 | 4 | 2 | 3 | 4 |
| 56 | 1 | 1 | 1 | 1 | 6 | 4 | 1 | 1 |
| 57 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 |
| 58 | 1 | 4 | 1 | 9 | 1 | 5 | 1 | 1 |
| 59 | 2 | 1 | 3 | 2 | 4 | 4 | 2 | 1 |
| 60 | 2 | 1 | 3 | 2 | 2 | 5 | 11 | 2 |
| 61 | 2 | 5 | 1 | 2 | 2 | 11 | 2 | 1 |
| 62 | 2 | 4 | 9 | 1 | 1 | 12 | 2 | 1 |
| 63 | 1 | 9 | 1 | 1 | 1 | 4 | 1 | 1 |
| 64 | 2 | 2 | 6 | 2 | 2 | 2 | 3 | 1 |
| 65 | 8 | 3 | 2 | 1 | 1 | 1 | 1 | 2 |
| 66 | 1 | 3 | 13 | 1 | 4 | 1 | 1 | 1 |
| 67 | 5 | 1 | 2 | 1 | 2 | 1 | 1 | 1 |
| 68 | 1 | 2 | 6 | 1 | 2 | 2 | 2 | 1 |
| 69 | 5 | 2 | 6 | 1 | 1 | 4 | 1 | 1 |
| 70 | 9 | 3 | 3 | 2 | 2 | 13 | 2 | 1 |
| 71 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 |
| 72 | 2 | 4 | 3 | 2 | 4 | 2 | 2 | 1 |
Figure 1Population snapshot of 165 isolates assigned to 72 sequence types (STs). STs connected by a line share six out of seven alleles. The dominant ST complex (STC9) which is named after its predicted founder is highlighted by a dotted circle.
Figure 2Minimum spanning tree based on allele profiles of 165 isolates and distribution of (A) host and ( B ) SpaA type (for Groups I-V see Table 4). Sequence types (STs) are indicated by numbers and sequence type complexes are highlighted by grey shade.
Substitutions in amino acids in the N-terminal hypervariable region of the spaA gene and number of C-terminal tandem repeats in 165 E. rhusiopathiae field isolates and serotype reference strains compared with the corresponding sequence of E. rhusiopathiae Fujisawa strainc
|
| Substitutions in N-terminal nucleotides (amino acid position)a,b | No. of C-terminal tandem repeats | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Nucleotide (aa 55) | Nucleotide (aa 70) | Nucleotide (aa 101) | Nucleotide (aa 178) | Nucleotide (aa 195) | Nucleotide (aa 203) | Nucleotide (aa 257) | Nucleotide (aa 303) | |||
| Fujisawa serotype 1a | GTA (Val) | AAA (Lys) | AAC (Asn) | GGT (Gly) | GAT (Asp) | ATT (Ile) | CTT Leu | GGG (Gly) | 9 | |
| Field isolates (No.) | Group I (87) |
| AA | G |
|
| G | 8-11, 13 | ||
| Group II (36) | A |
| 7-10 | |||||||
| Group III (37) |
| 8, 9 | ||||||||
| Group IV (1) |
| G | 8 | |||||||
| Group V (4) | AT |
| 9 | |||||||
| Serotype reference strains | Serotype 1a (Koganei) 5, 15 |
| AA | G |
|
| G | 9 | ||
| Serotype 8, 17 | A |
| 9 | |||||||
| Serotype 1b, 9, 12, 16, N |
| 8, 9 | ||||||||
| Serotype 2 |
| AA |
| 9 | ||||||
aAsp aspartic acid; Asn asparagine; Gln glutamine; Ile isoleucine; Leu leucine; Lys lysine; Met methionine; Val valine.
bUnderlined character, nucleotide different from those at the same position; empty fields indicate absence of amino acid substitutions compared with the Fujisawa strain.
cNucleotide sequences of spaA genes of Fujisawa strain and of E. rhusiopathiae serotype reference strains were obtained from GenBank (AB259652, strain Fujisawa, serotype 1a; AB024082, Koganei, serotype 1a; AB259653, 442/1E1, serotype 1b; AB259654, ATCC19414T, serotype 2; AB259655, Pècs 67, serotype 5; AB259656, Goda, serotype 8; AB290347, Kaparek, serotype 9; AB259657, Pècs 9, serotype 12; AB259658, Pècs 3597, serotype 15; AB259659, Tanzania, serotype 16; AB259660, 545, serotype 17; AB259661, MEW22, serotype N) and translated into amino acid sequences using RidomSeqSphere. Reference strains for other serotypes were not included as they chiefly harbor spaB genes (serotypes 4, 6, 11, 19, and 21) or a spaC gene (serotype 18), respectively [15].
Figure 3Dendrogram for isolates based on PFGE banding patterns produced by SmaI restriction. Illustrated are dendrograms for (A) 45 E. rhusiopathiae isolates of sequence type complex (STC) 9 and isolates of other STs clustering with ST9 strains and (B) 11 ST4 isolates that do not cluster with strains of other STs. Additional information on isolation year and country, host, SpaA-groups (based on amino acid substitutions) and the number of SpaA C-terminal repeats are provided in separate rows. PFGE clusters (85% cut-off) are indicated by random colours; singletons are left black.